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Ethnopharmacological  relevance:  The  tea  from  the  stem  bark  of Caesalpinia  ferrea  Martius  (Leguminosae)
has  been  popularly  used  in  the  treatment  of  diabetes  in  Brazil.
Aim  of the  study:  To  investigate  the  hypoglycaemic  properties  and  to elucidate  the  mechanisms  by  which
the  aqueous  extract  of  the  stem  bark  of  Caesalpinia  ferrea  reduces  blood  glucose  levels  in  streptozotocin-
induced  diabetic  rats  via  the  enzymatic  pathways  of  protein  kinase  B  (PKB/Akt),  AMP-activated  protein
kinase  (AMPK)  and  acetyl-CoA  carboxylase  (ACC).
Materials  and  methods:  The  aqueous  extract  of  the  stem  bark  of Caesalpinia  ferrea  (300  and 450  mg/kg/day),
vehicle  and  metformin  (500  mg/kg/day)  were  administered  orally  to STZ-diabetic  rats  (n =  7/group)  for  4
weeks.  Changes  in  body  weight,  food  and  water  intake,  fasting  glucose  levels  and  oral  glucose  tolerance
were  evaluated.  Phosphorylation  (P) and  the  expression  of  Akt,  AMPK  and  ACC  in  the  liver  and  skeletal
muscle  were  determined  using  Western  blot.
Results: The  aqueous  extract  of  the  stem  bark  of  Caesalpinia  ferrea  reduced  blood  glucose  levels  and
improved  the  metabolic  state  of the  animals.  P-Akt  was  increased  in  the  liver  and  skeletal  muscle  of
the  treated  animals,  P-AMPK  was  reduced  only  in  the  skeletal  muscle  of  these  animals  and  P-ACC  was
reduced  in  both  when  compared  with  untreated  rats.
Conclusion:  The  results  indicate  that  the  aqueous  extract  of  the  stem  bark  of Caesalpinia  ferrea has  hypo-
glycaemic  properties  and  possibly  acts  to  regulate  glucose  uptake  in  liver  and  muscles  by  way  of  Akt
activation,  restoring  the  intracellular  energy  balance  conﬁrmed  by  inhibition  of  AMPK  activation.
 . Introduction
Diabetes is a group of metabolic diseases characterized by
yperglycaemia resulting from defects in insulin secretion, insulin
ction, or both. The chronic hyperglycaemia of diabetes is associ-
ted with long-term damage, dysfunction, and failure of different
rgans, especially the eyes, kidneys, nerves, heart, and blood vessels
ADA, 2010).The pharmacological treatment of diabetes includes oral hypo-
lycaemic and insulin. Although these drugs are effective in
educing glycaemia, they may  cause undesirable side effects (such
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as weight gain, hypoglycemia, edema, gastrointestinal disturbances
and insulin resistance) that can discourage patient compliance.
On the other hand, ethnopharmacological evidence has shown
that the use of plants is a viable alternative for the treatment
of diabetes. The advantages of herbal medicine include signiﬁ-
cant efﬁcacy, low incidence of side effects, low cost and relative
safety (Ali et al., 2006). In fact, the medicinal plants are considered
an important source of molecules with potential hypoglycaemic
effects. Grover et al. (2002) have reported about 800 plants with
these molecules, which may act through different mechanisms,
including the inhibition or stimulation of enzymatic activity and/or
protein expression. The wide diversity of species has led scientists
to make great efforts to bioprospect plants that may  contribute to
Open access under the Elsevier OA license.the management of diabetes.
Caesalpinia ferrea Martius (Leguminosae), popularly known as
“pau-ferro” or “jucá”, is a large tree that is found mainly in the
North and Northeast of Brazil. In folk medicine, the tea of the
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tem bark of Caesalpinia ferrea has been used for the treatment
f diabetes (Araújo et al., 2008). Other therapeutic properties of
his plant include anti-inﬂammatory, antiulcer (Bacchi and Sertié,
994; Bacchi et al., 1995), analgesic (Carvalho et al., 1996), anti-
ancer (Nozaki et al., 2007), antibacterial (Sampaio et al., 2009) and
ntihypertensive (Menezes et al., 2007). In view of its ethnomedic-
nal importance, the Brazilian Ministry of Health has included this
pecies on the National List of Medicinal Plants important to the
ealth System.
Phytochemical investigation of the hydroalcoholic extract of the
tem bark and leaves of Caesalpinia ferrea has revealed ﬂavonoids,
aponins, tannins, coumarins, steroids and other phenolic com-
ounds (Gonzalez et al., 2004). Tannins were the main compounds
ound (Souza et al., 2006). One component isolated from the fruit
s ellagic acid, inhibitor of aldose reductase, which is an enzyme
nvolved in the complications of diabetes (Ueda et al., 2001).
Although Caesalpinia ferrea is widely used in folk medicine,
here is no experimental evidence proving its hypoglycaemic prop-
rties. The aim of this study was, therefore, to investigate the
ypoglycaemic properties of the stem bark of Caesalpinia ferrea in
treptozotocin-induced diabetic rats and to examine the effects of
ts aqueous extract on the phosphorylation and expression of pro-
ein kinase B (PKB/Akt), AMP-activated protein kinase (AMPK) and
cetyl-CoA carboxylase (ACC) in skeletal muscle and the liver. The
ctivation of these enzymes contributes to reduction of glycaemia
y increasing glucose uptake in the tissues (Farese et al., 2005).
. Materials and methods
.1. Plant material and extraction
Bark from the stem of Caesalpinia ferrea Mart. Ex Tul.
as collected from the Amazon Research National Institute
INPA) experimental culture, in the Brazilian State of Amazonas
03◦05′48.0′′S and 59◦59′55.0′′W.Gr). The voucher specimen of
he plant was deposited at the INPA herbarium under number
28022. The bark was collected in September 2009, March 2010
nd September 2010, with approximately 3 kg being harvested on
ach occasion. The material collected was dried, ﬁrst at room tem-
erature for 48 h, and then taken to an oven with circulating air at a
emperature of 45 ± 2 ◦C until its weight stabilized. Subsequently,
he material was ground in a 1 mm mesh knife mill, thereby pro-
iding the raw material (MPV). The aqueous extract of Caesalpinia
errea was prepared by raw material infusion (7.5:100, w/v) using
oiling distilled water as the extractive solvent for a period of
5 min. The aqueous extract presented a solid soluble content of
.6 ± 0.02 g%. The aqueous extract was dried using a MSD  1.0 Lab-
aq  Mini Spray Dryer. The drying process was performed using
he following parameters: inlet temperature of 120 ◦C, compressed
ir pressure of 2 bar, diameter rotor of 0.7 mm  and power ﬂow of
0 mL/min. The yield of dry extract after drying of aqueous extract
as 98%, representing 5.88 g of dry extract per liter of aqueous
xtract of Caesalpinia ferrea.
.2. Phytochemical analysis of Caesalpinia ferrea
.2.1. Thin layer chromatographic (TLC) analysis of Caesalpinia
errea
The methods described by Wagner and Bladt (1996) were used
o screen the dried bark extract for the hydrolysable tannins (gal-
ic and ellagic acids), condensed tannins (catechins), ﬂavonoids,
aponins, coumarins, phenylpropanoids, cinnamic acid derivatives,
lkaloids, triterpenoids/steroids, monoterpenes, sesquiterpenes,
ridoids, sugars and luteolin. The phytochemical proﬁle was  drawn
p using thin layer chromatography (TLC) on silica gel platesharmacology 137 (2011) 1533– 1541
(Merck® art. 105553, UV 250–366 nm)  using the appropriate
mobile phase, reagents and standards.
2.2.2. Estimation of total tannin content in Caesalpinia ferrea
The total tannin content was  determined using the spray dried
extract (SDE) of Ceasalpinia ferrea aqueous extract at 7.5% (w/v),
by way  of the difference between redissolved SDE before and after
precipitation with 150 mg  of casein (Merck® Germany). The mea-
surements were performed at 270 nm and the total tannin content
was calculated as gallic acid (mg/g of SDE). The results represent
the mean of three measurements.
2.2.3. High performance liquid chromatography (HPLC) analysis
of Caesalpinia ferrea
The main phytochemical markers (gallic acid, ellagic acid, cate-
chin and epicatechin) were quantiﬁed by way  of LC-DAD analysis
using a Shimadzu system (LC-20AT) equipped with a photo diode
array detector (SPD-M20A). The chromatographic separation was
performed using a Gemini RP-18 column 240 × 4 mm i.d. (Phe-
nomenex), protected by a pre-column packet of the same material.
A gradient elution was  performed by varying the proportion of sol-
vent B (methanol) to solvent A (acetic acid 0.5%, w/w) at a ﬂow
rate of 0.8 mL/min, according to the following gradient program:
20–40% B (10 min), 40–60% B (10 min), 60% B (10 min), 60–40%
B (10 min), and 40–20% B (10 min). The SDE of Caesalpinia ferrea
and standard were dissolved in methanol:water (20/80, v/v) and
ﬁltered through a 0.45 m membrane (Millipore®, USA) prior to
injection of 20 L.
The peaks of each marker substance in the dried extract were
initially identiﬁed by comparing the retention time and UV-
spectrums. After that, the peaks were conﬁrmed by spiking the
sample with a small amount of the standards.
2.3. Animals
Male Wistar rats (Rattus norvegicus var. albinus) (aged 2 months,
weighing 280–300 g) were obtained from the Department of Phys-
iology and Pharmacology at the Federal University of Pernambuco
(UFPE), Pernambuco, Brazil. The animals were kept under stan-
dard environmental conditions (22 ± 2 ◦C); 12:12 h dark/light cycle.
Water and industrialized dry food (Labina®, Purina, Brazil) were
made available ad libitum.  The experimental protocol was  approved
by the Animal Experimentation Ethics Committee of UFPE (Pro-
cess no. 01411), in accordance with the National Institute of Health
Guidelines for the Care and Use of Laboratory Animals.
2.4. Induction of experimental diabetes
Diabetes was  induced using streptozotocin (STZ) from
Sigma–Aldrich®, St. Louis, MO,  USA. The animals fasted overnight
and diabetes was induced by way of a single intra peritoneal
injection of a freshly prepared solution of STZ (50 mg/kg b.w.) in a
0.1 M citrate buffer (pH 4.5). On the third day of STZ-injection, the
animals with fasting glycaemia higher than 200 mg/dL and with
signs of polyuria and polydipisia were considered to be diabetic
and included in the study.
2.5. Diabetic animals
2.5.1. Treatment
In the experiment, the animals were randomly divided intoﬁve groups (n = 7/group). Group 1 (NDC-non-diabetic control) and
group 2 (DC-diabetic control) consisted of rats treated with vehi-
cle (water); group 3 (MTD-diabetic rats treated with metformin
500 mg/kg/day b.w.), groups 4 and 5 (diabetic rats treated with
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he aqueous extract of the stem bark of Caesalpinia ferrea 300 and
50 mg/kg/day b.w.).
The selected doses (300 and 450 mg/kg/day of b.w.) of extract
f Caesalpinia ferrea were based on prior study of their analgesic,
nti-inﬂammatory and antiulcer activities (Bacchi and Sertié, 1994;
acchi et al., 1995; Carvalho et al., 1996) and reports of the local
ommunity who use the tea 1–3 times a day before meals.
Treatment was administered orally on a daily basis in a single
ose for 28 consecutive days. Fasting glucose and body weight were
ecorded weekly, while food and water intake were monitored
aily.
.5.2. Oral glucose tolerance test (OGTT) in STZ-diabetic rats
On the 25th day of treatment, the animals from groups 1 to
 fasted for 12 h. Fasting glycaemia was measured and deﬁned
s zero time. After this procedure, animals received their treat-
ent orally and after 30 min, all groups received an oral load of
-glucose (2.0 g/kg b.w.). Blood glucose levels were measured 30,
0, 120 and 150 min  after glucose administration. Blood samples
ere obtained by retro-orbital puncture under anesthesia with
embutal® (25 mg/kg, i.p.) using Architect (Abbott®) automation
ith Boehringer Ingelheim® biochemical kits.
.5.3. Biochemical parameters
At the end of treatment, blood samples were centrifuged
t 1500 × g for 10 min  to obtain serum, which was  stored at
20 ◦C until the following parameters had been determined:
lucose, blood urea nitrogen (BUN), uric acid, aspartate aminotrans-
erase (AST), alanine aminotransferase (ALT); alkaline phosphatase
AlkP), total cholesterol (TC), and triglycerides. Dosages were made
sing Architect (Abbott®) automation with Boehringer Ingelheim®
iochemical kits. Liver glycogen was determined using the colori-
etric method.
.5.4. Liver and tissue mass analysis
Once blood had been collected, the animals were euthanized
ith an excess of Nembutal® (140 mg/kg, i.p.). Liver, epididymal
dipose tissue, soleus and extensor digitorium longus muscles were
arefully removed, individually weighed and expressed in absolute
nd relative terms (g and g/100 g b.w., respectively).
.5.5. Evaluation of serum and liver oxidative stress
Once blood had been collected and the liver resected, oxida-
ive stress was evaluated using levels of thiobarbituric acid-reactive
ubstances (TBARS). One gram of tissue was macerated in 5 mL  of
.15% KCl/g in an ice bath. Subsequently, 1 mL  of 0.375% (w/v) thio-
arbituric acid (Sigma–Aldrich®, St. Louis, MO, USA) in 75% (w/v)
richloroacetic acid (TCA) (Vetec®, Rio de Janeiro, Brazil) was  added
or each milliliter of tissue homogenate. The same methodology
as used for analysis of serum (1 mL). The tubes were sealed and
eated in a water bath at 100 ◦C for 15 min. After cooling, the protein
recipitate was centrifuged at 3000 × g for 10 min  at room temper-
ture, the supernatant separated and the absorbance measured at
35 nm.
.5.6. Histopathological examination of the pancreas
Histopathological analyses were performed by way of optical
icroscopy on parafﬁn material. Pancreas tissue sections were
xed in 10% buffered formalin. After ﬁxation, the sample was
ashed with water, immersed in 70% ethyl alcohol for 3–4 days
nd embedded in parafﬁn. Parafﬁn sections of 5 m were obtained
rom rotational microtome and stained with hematoxylin and eosin
HE).
The criteria used for scoring the injuries to the pancreas were as
ollows Li et al. (2001).  Score 0, normal (the normal numbers and
olume of the islet cells); score I, minor injury (the numbers of isletharmacology 137 (2011) 1533– 1541 1535
cells were slightly lower and islet cells were slightly swollen); score
II, moderate injury (the numbers of islet cells were moderately
lower and islet cells were moderately swollen); score III, obvious
injury (the numbers of islet cells were obviously lower and islet
cells were obviously swollen); score IV, severe injury (the numbers
of islet cells were severely reduced and islet cells were severely
swollen).
2.5.7. Determination of basal plasma insulin
Basal plasma insulin concentrations were determined by
radioimmunoassay and measured with a Beckman Gamma 5500
Counter (Beckman Instruments®, Fullerton, CA). The kit (Diagnos-
tic Products Corporation®) included human insulin as the standard
and 125I-labelled human insulin as the antibody, which cross-reacts
with rat insulin.
2.5.8. Western blotting
Protein extraction and immunoblotting were carried out as
previously reported (Rafacho et al., 2009) with modiﬁcations. Frag-
ments of soleus muscle and liver were obtained from animals and
ﬁrst homogenized in an ice-cold cell lysis buffer (Cell Signaling®)
using a Polytron PT 1200C homogenizer (Brinkmann Instruments®,
NY, USA) (2 pulses of 15 s at the maximum speed) and subsequently
sonicated in a cell homogenizer (Fisher Scientiﬁc®, Suwanee, GA,
USA) for 2 pulses of 15 s at the intermediate speed. Protein con-
centration from total cell lysate was measured using the Bradford
method, according to the manufacturer (Bio-Rad Laboratories®,
Hercules, CA, USA). For each experiment, 150 g of protein obtained
from muscle and hepatic tissue was separated by SDS-PAGE, trans-
ferred to nitrocellulose membranes and stained with Ponceau S. The
protein kinase B (Akt), AMP-activated protein kinase (AMPK) and
acetyl-CoA carboxylase (ACC), in their total and phosphorylated
forms (P-Akt, P-AMPK and P-ACC) were detected in the mem-
brane after 2 h of incubation at room temperature with polyclonal
antibodies (Santa Cruz Biotechnology®, CA, USA). Detection was
performed using enhanced chemiluminescence (SuperSignal West
Pico®, Pierce, Rockford, IL) after incubation with a peroxidase-
conjugated secondary antibody. Band intensities were quantiﬁed
using optical densitometry (Scion Image®, Frederick, MD)  of the
developed autoradiogram.
2.6. Normoglycaemic animals
2.6.1. Effect of the aqueous extract of the stem bark of Caesalpinia
ferrea on intestinal absorption of glucose
Healthy normoglycaemic rats fasted for 16 h and were randomly
divided into three groups (n = 7/group). Groups 1, 2 and 3 received
1 mL  of water, 1 mL  of metformin (120 mg/kg b.w.) and 1 mL of the
aqueous extract of the stem bark of Caesalpinia ferrea 450 mg/kg
b.w., respectively. After 30 min, all groups received an oral solu-
tion of d-glucose 50% (10 mL/kg b.w.) and, after 1 h, all animals
were euthanized with an excess Nembutal® (140 mg/kg, i.p.) and
their small intestine removed. Then, the intestine was perfused
with 50 mL  of water and the contents collected at the other end,
centrifuged at 1500 × g for 5 min  and the supernatant used to deter-
mine the value of glucose by way  of spectrophotometry.
2.7. Statistical analysis
The results were expressed as mean ± standard error of mean
(S.E.M.). Statistical analysis was  performed using Graph Pad Prism
5.0® software. The difference between groups was assessed by
analysis of variance (ANOVA), followed, when necessary, by
Newman–Keuls test. The signiﬁcance level for rejection of the null
hypothesis was  always ≥5% (p < 0.05).
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Fig. 3. Effect of aqueous extract of Caesalpinia ferrea (Cf) on body mass gain (g) of
diabetic rats (NDC: non-diabetic control; DC: diabetic control, MTD: diabetic rats
treated with metformin 500 mg/kg; Cf: diabetic rats treated with aqueous extract
of  the stem bark of Caesalpinia ferrea 300 and 450 mg/kg). The results are expressed
aig. 1. Chromatogram of Caesalpinia ferrea SDE detected at 270 nm.  Peaks: (1) gallic
cid; (2) catechin; (3) epicatechin and (4) ellagic acid.
. Results
.1. Phytochemical screening of Caesalpinia ferrea
TLC for chemical identiﬁcation of the constituents of Caesalpinia
errea bark revealed the presence of condensed tannins (catechins)
nd hydrolysable tannins (gallic and ellagic acids). The total tannin
ontent of Caesalpinia ferrea SDE was calculated as 266 mg/g. On
he other hand, the content for HPLC of gallic acid (1), catechin
2), epicatechin (3) and ellagic acid (4) was 112.76, 17.75, 6.13 and
2.00 mg/g (Fig. 1).
.2. STZ-diabetic animals
.2.1. The effect of treatment with the aqueous extract of the stem
ark of Caesalpinia ferrea on fasting blood glucose
Oral administration of Caesalpinia ferrea 300 and 450 mg/kg/day
.w. in diabetic rats showed signiﬁcant reductions in fasting glucose
evels of more than 50% already in the ﬁrst week of treatment when
ompared to DC and MTD. At the end of treatment, this reduction
as of 70 and 79.5%, respectively, only in relation to DC (Fig. 2).
.2.2. The effect of treatment with the aqueous extract of the stem
ark of Caesalpinia ferrea on body mass gain, food and water
ntake
Figs. 3–5 show the evolution of body mass gain, food and water
ntake in the experimental groups during the 28-day treatment,
espectively. Throughout the study, body mass gain of the group
eceiving 450 mg/kg/day of Caesalpinia ferrea was signiﬁcantly
igher than that of other groups. 300 mg/kg/day of Caesalpinia fer-
ea did not show statistical differences for this parameter (Fig. 3).
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ig. 2. Effect of aqueous extract of Caesalpinia ferrea (Cf) on fasting blood glucose
mg/dL) of diabetic rats (NDC: non-diabetic control; DC: diabetic control, MTD: dia-
etic rats treated with metformin 500 mg/kg; Cf: diabetic rats treated with aqueous
xtract of the stem bark of Caesalpinia ferrea 300 and 450 mg/kg). The results are
xpressed as mean ± S.E.M. (n = 7/group). aStatistically different from DC and MTD.
Statistically different from DC (ANOVA followed by Newman–Keuls, p < 0.05).as  mean ± S.E.M. (n = 7/group). Statistically different from DC and MTD  (ANOVA
followed by Newman–Keuls, p < 0.05).
The results shown in Fig. 4 also reveal a signiﬁcant reduction in
food intake in the group receiving Caesalpinia ferrea 450 mg/kg/day
from the ﬁrst week of the study until the end of the treatment
when compared with DC. Statistical reduction in relation to MTD
occurred since the third week. The group treated with Caesalpinia
ferrea 300 mg/kg/day showed reductions in food intake only in the
ﬁrst and third week of the study when compared with DC.
Polydipsia was signiﬁcantly reduced in the group receiving Cae-
salpinia ferrea 450 mg/kg/day already in ﬁrst week of treatment
compared to DC and, in the following weeks, this reduction was  also
signiﬁcant for the DC and MTD. The group receiving Caesalpinia fer-
rea 300 mg/kg/day showed signiﬁcant reductions from the second
week only compared to the DC (Fig. 5).
As Caesalpinia ferrea 450 mg/kg/day b.w. was the most effective
during the treatment, this dose was  selected for further studies.
3.2.3. The effect of the aqueous extract of the stem bark of
Caesalpinia ferrea on glucose tolerance
Table 1 shows the blood glucose levels of the NDC, DC, MTD  and
Caesalpinia ferrea 450 mg/kg b.w. groups after oral administration
of d-glucose (2.0 g/kg b.w.). Caesalpinia ferrea 450 mg/kg showed
signiﬁcant decrease in glycaemia from 30 min  after glucose admin-
istration when compared to other groups. Reductions of 70, 69, 76
and 80% were observed in glycaemic levels of this group in 30, 60,
120 and 150 min, respectively, when compared to DC.
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Fig. 4. Effect of aqueous extract of Caesalpinia ferrea (Cf) on food intake
(g/day/animal) of diabetic rats (NDC: non-diabetic control; DC: diabetic control,
MTD: diabetic rats treated with metformin 500 mg/kg; Cf: diabetic rats treated
with aqueous extract of the stem bark of Caesalpinia ferrea 300 and 450 mg/kg). The
results are expressed as mean ± S.E.M. (n = 7/group).aStatistically different from DC
and MTD. bStatistically different from DC. cStatistically different from MTD  (ANOVA
followed by Newman–Keuls, p < 0.05).
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Fig. 5. Effect of aqueous extract of Caesalpinia ferrea (Cf) on water intake
(mL/day/animal) in diabetic rats (NDC: non-diabetic control; DC: diabetic control;
MTD: diabetic rats treated with metformin 500 mg/kg; Cf: diabetic rats treated with
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.2.4. Biochemical parameters
Biochemical parameters of Caesalpinia ferrea 450 mg/kg/day
howed statistically signiﬁcant reductions in urea, uric acid, AST
nd ALT levels when compared to DC and signiﬁcant increases in
epatic glycogen, total cholesterol and triglycerides in relation to
able 1
ffect of the aqueous extract of the stem bark of Caesalpinia ferrea on oral glucose toleran
Time NDC DC 
0 (fasting) 88.6 ± 7.2 426.3 ± 19
30 min 110.0 ± 5.4 642.7 ± 12
60 min 104.1 ± 6.1 637.0 ± 13
120 min  101.0 ± 3.4 618.3 ± 9.3
150 min 97.0 ± 3.1 598.3 ± 4.4
DC, non-diabetic control; DC, diabetic control; MTD, diabetic rats treated with metfor
aesalpinia ferrea 450 mg/kg. The values are expressed as mean ± S.E.M. (n = 7/group).
a Statistically different from DC and MTD (ANOVA followed by Newman–Keuls, p < 0.05
able 2
iochemical parameters of normoglycaemic and diabetic rats.
Parameters NDC DC 
Urea (mg/dL) 28.80 ± 1.25 101.00 ± 8
UA (mg/dL) 1.10 ± 0.07 3.05 ± 0
AST (U/L) 153.70 ± 8.00 596.20 ± 9
ALT (U/L) 52.57 ± 2.30 406.70 ± 9
AlkP (U/L) 234.00 ± 9.21 1814.00 ± 9
L Gly (mg%) 2.61 ± 0.19 0.13 ± 0
TC (mg/dL) 77.58 ± 5.15 60.78 ± 2
Trig (mg/dL) 47.07 ± 3.94 35.77 ± 3
A, uric acid; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AlkP, alkali
on-diabetic control; DC, diabetic control; MTD, diabetic rats treated with metformin 500
errea  450 mg/kg. The values are expressed as mean ± S.E.M. (n = 7/group).
a Statistically different from DC and MTD.
b statistically different from DC (ANOVA followed by Newman–Keuls, p < 0.05).
able 3
ffect of the aqueous extract of the stem bark of Caesalpinia ferrea on tissues masses of di
Parameters NDC DC 
Liver (g) 13.56 ± 0.75 8.44 ± 0.44
(g/100 g) 4.01 ± 0.11 3.77 ± 0.22
EAT (g) 2.25 ± 0.01 0.57 ± 0.09
(g/100 g) 0.90 ± 0.02 0.24 ± 0.09
Soleus (g) 0.158 ± 0.002 0.112 ± 0.00
(g/100 g) 0.052 ± 0.002 0.078 ± 0.02
EDL  (g) 0.162 ± 0.003 0.089 ± 0.00
(g/100 g) 0.060 ± 0.004 0.040 ± 0.00
AT, epididymal adipose tissue; Soleus,  soleus muscle; EDL, extensor digitorium longus mus
etformin 500 mg/kg; Cf, diabetic rats treated with aqueous extract of the stem bark of Ca
a Statistically different from DC and MTD (ANOVA followed by Newman–Keuls, p < 0.05harmacology 137 (2011) 1533– 1541 1537
same group. AlkP levels were statistically lower than DC and MTD
(Table 2).
3.2.5. Liver and tissue mass analysis
The effects of Caesalpinia ferrea 450 mg/kg/day on masses
of liver, epididymal adipose tissue, soleus and extensor digi-
torium longus muscles are given in Table 3. Caesalpinia ferrea
450 mg/kg/day showed a signiﬁcant increase in liver and tissues
masses in relation to DC and MTD, except for the relative mass of
soleus muscle.
3.2.6. Evaluation of serum and liver oxidative stress
Oxidative stress present in diabetic animals was measured
by levels of thiobarbituric acid-reactive substances (TBARS).
Caesalpinia ferrea 450 mg/kg/day b.w. showed levels of TBARS
signiﬁcantly lower in serum (2.60 ± 0.15 nmol MDA/mL, p < 0.05)
and liver (23.81 ± 1.30 nmol MDA/g of hepatic tissue, p < 0.05)
when compared to the diabetic control (3.34 ± 0.25 nmol MDA/mL
and 27.82 ± 0.38 nmol MDA/g, respectively). The metformin group
also showed levels of serum and liver TBARS signiﬁcantly
lower (2.80 ± 0.10 nmol MDA/mL and 24.82 ± 0.22 nmol MDA/g,
respectively, p < 0.05) in relation to the diabetic control. The
non-diabetic control showed levels of serum and liver TBARS
ce test (mg/dL), after oral administration of d-glucose (2.0 g/kg).
MTD  Cf 450
.7 297.0 ± 14.5 123.0 ± 9.0a
.9 385.5 ± 10.5 192.0 ± 8.3a
.9 396.0 ± 9.4 197.0 ± 8.5a
 290.0 ± 8.4 149.0 ± 5.0a
 260.0 ± 8.1 120.0 ± 3.0a
min 500 mg/kg; Cf, diabetic rats treated with aqueous extract of the stem bark of
).
MTD  Cf 450
.33 70.75 ± 7.46 34.20 ± 2.42b
.18 0.97 ± 0.02 1.02 ± 0.03b
.70 212.30 ± 10.40 148.60 ± 5.61b
.50 139.80 ± 9.44 62.80 ± 4.83b
.98 656.30 ± 6.99 179.20 ± 7.82a
.06 0.53 ± 0.01 1.72 ± 0.01b
.95 70.75 ± 5.63 99.20 ± 7.89b
.28 139.30 ± 7.49 70.00 ± 6.38b
ne phosphatase; L Gly, liver glycogen; TC, total cholesterol; Trig, triglycerides; NDC,
 mg/kg; Cf, diabetic rats treated with aqueous extract of the stem bark of Caesalpinia
abetic rats.
MTD  Cf 450
 8.36 ± 0.18 13.20 ± 0.47a
 3.83 ± 0.06 4.81 ± 0.09a
 0.12 ± 0.03 1.59 ± 0.30a
 0.05 ± 0.01 0.57 ± 0.09a
7 0.101 ± 0.006 0.135 ± 0.003a
7 0.046 ± 0.002 0.048 ± 0.002
8 0.079 ± 0.002 0.158 ± 0.002a
3 0.036 ± 0.001 0.058 ± 0.004a
cle; NDC, non-diabetic control; DC, diabetic control; MTD, diabetic rats treated with
esalpinia ferrea 450 mg/kg. The values are expressed as mean ± S.E.M. (n = 7/group).
).
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Fig. 6. Parafﬁn sections of pancreas (HE) of STZ-diabetic rats. (A) Non-diabetic control (magniﬁcation 100×); (B) diabetic control (magniﬁcation 400×); (C) diabetic rats
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ireated with metformin 500 mg/kg (magniﬁcation 400×); (D) diabetic rats treated
00×).
f 1.21 ± 0.09 nmol MDA/mL and 14.00 ± 0.32 nmol MDA/g, respec-
ively).
.2.7. Histopathological examination of the pancreas
All groups in the study had similar patterns of destruction of
slets. STZ administration caused severe injury to the pancreas, such
s a decrease in the number of islet cells and a reduction in the
iameter of pancreatic islets. The islets were shrunken with atyp-
cal cellular changes, such as mild hyperchromasia, anysokariosis,
oarse chromatin and pyknosis (Fig. 6).
.2.8. Determination of basal plasma insulin
The plasma insulin levels were drastically reduced in all
roups of STZ-diabetic rats at the end of treatment and no sta-
istical difference was found between DC (0.58 ± 0.07 ng/mL),
TD  (0.74 ± 0.08 ng/mL) and Caesalpinia ferrea 450 mg/kg/day
0.76 ± 0.06 ng/mL). The plasma insulin levels of non-diabetic con-
rol were 3.56 ± 0.15 ng/mL.
.2.9. Western blotting
Since glucose tolerance was markedly improved with Cae-
alpinia ferrea 450 mg/kg/day b.w. administration without stimu-
ating plasma insulin secretion, we decided to investigate the role
f liver and soleus muscle in this process. We  thus analyzed the
xpression of total and phosphorylated levels of Akt, AMPK and
CC in both tissues of experimental rats. The soleus muscle of rats
n the Caesalpinia ferrea 450 mg/kg/day b.w. group displayed a 52%
ncrease in the expression of P-Akt and reductions of 20% and 40%
n terms of P-AMPK and P-ACC, respectively, when compared to the
iabetic control group (p < 0.05, Fig. 7). No changes were observed in
otal protein content among the groups. For the liver, a 41% increase
as also observed for P-Akt, but no statistical difference was  found
n expression of P-AMPK, although there was a 20% reduction of aqueous extract of the stem bark of Caesalpinia ferrea 450 mg/kg (magniﬁcation
P-ACC in relation to the diabetic control group (p < 0.05, Fig. 8).
Together, these results suggest increased glucose uptake.
3.3. Normoglycaemic animals
3.3.1. The effect of the aqueous extract of the stem bark of
Caesalpinia ferrea on intestinal absorption of glucose
The intestinal absorption of glucose was signiﬁcantly inhibited
in normoglycaemic rats treated with aqueous extract of Caesalpinia
ferrea 450 mg/kg b.w. in relation to control animals, but it did
not differ statistically from the group treated with metformin
(120 mg/kg b.w.) (Fig. 9).
4. Discussion
The experiments in this study were designed to investigate the
hypoglycaemic activity of the aqueous extract of the stem bark
of Caesalpinia ferrea,  as well as the possible role of the enzymatic
pathways of protein kinase B (PKB/Akt) and AMP-activated protein
kinase (AMPK).
The use of Caesalpinia ferrea in folk medicine is well known. In
Brazil, many diabetic patients take tea made from the stem bark
of Caesalpinea ferrea daily to control glycaemic levels (Teixeira and
Melo, 2006). This is important from an ethnopharmacological point
of view, because our study has provided the ﬁrst experimental evi-
dence of the hypoglycaemic properties of aqueous extract of the
stem bark of Caesalpinia ferrea in streptozotocin-induced diabetic
rats. Our work opens the way  for further chemical, pharmacologi-
cal and toxicological research into the development of traditional
medicine.
The animals treated daily with Caesalpinia ferrea 450 mg/kg had
improved their metabolic state through increased glucose toler-
ance. This dose was therefore chosen for the other tests.
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Fig. 7. Western blot analysis of Akt, AMPK and ACC in skeletal muscle of STZ-diabetic rats (NDC: non-diabetic control; DC: diabetic control; MTD: diabetic rats treated with
metformin 500 mg/kg; Cf: diabetic rats treated with aqueous extract of the stem bark of Caesalpinia ferrea 450 mg/kg). The results are expressed as mean ± S.E.M. and indicate
the  relationship between phosphorylated protein and total protein (n = 7/group). Means without a common letter differ, p < 0.05 (ANOVA followed by Newman–Keuls).
Fig. 8. Western blot analysis of Akt, AMPK and ACC in the liver of STZ-diabetic rats (NDC: non-diabetic control; DC: diabetic control; MTD: diabetic rats treated with
metformin 500 mg/kg; Cf: diabetic rats treated with aqueous extract of the stem bark of Ca
the  relationship between phosphorylated protein and total protein (n = 7/group). Means w
F
(
o
t
m
lig. 9. Intestinal glucose concentration (mg/dL) in normoglycaemic Wistar rats
Control: rats treated with 1 mL  of water; metformin: rats treated with 1 mL
f  metformin 120 mg/kg; Cf: rats treated with 1 mL  of aqueous extract of
he  stem bark of Caesalpinia ferrea 450 mg/kg). The results are expressed as
ean ± S.E.M. (n = 7/group). *Statistically different from the control (ANOVA fol-
owed by Newman–Keuls, p < 0.05).esalpinia ferrea 450 mg/kg). The results are expressed as mean ± S.E.M. and indicate
ithout a common letter differ, p < 0.05 (ANOVA followed by Newman–Keuls).
The major compounds of the aqueous extract of the stem
bark of Caesalpinia ferrea are condensed tannins (catechins) and
hydrolysable tannins (gallic acid and ellagic acid). The effect of
reducing blood glucose levels could not be attributed to hydrolyz-
able tannins, since Ueda et al. (2004) have shown that ellagic acid
obtained from the fruit of Caesalpinia ferrea does not reduce blood
glucose of diabetic animals, but only inhibits aldose reductase,
minimizing the complications of diabetes. However, the catechins
present in the aqueous extract of ﬂower of Eugenia operculata
(500 mg/kg) reduced fasting glucose in diabetic rats after 8 weeks of
treatment (Mai  and Chuyen, 2007). In fact, the catechins and their
derivates are known for their hypoglycaemic properties and act to
control diabetes (Kao et al., 2000). Thus, it is reasonable to infer
that these compounds could be responsible for the hypoglycaemic
effect in our study.Our results indicate that the hipoglycaemic properties of the
aqueous extract of the stem bark of Caesalpinia ferrea is an extra-
pancreatic effect, independent of insulin secretion, since insulin
levels remained low after treatment.
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In order to clarify how the aqueous extract of the stem bark
f Caesalpinia ferrea exerts its hipoglycaemic action, the molecular
echanisms that involve Akt, AMPK and acetyl-CoA carboxylase
ACC) signaling were investigated.
The activation of Akt is required for the regulation of glycogen
ynthesis in muscle, adipocytes, liver and for inhibition of gluco-
eogenesis. The increase in hepatic glycogen in treated animals,
s a consequence of the activation of Akt, conﬁrms its action on
lycogen synthase as described by Farese et al. (2005).  According
o Liu et al. (2010),  the activation of Akt in insulin-resistant rats
as improved by treatment with polysaccharide from Astragulus
embranaceus.
In skeletal muscle, the activation of Akt also increases glucose
ptake by translocation of GLUT 4 from the cytosol to the plasma
embrane and, as a consequence, reduces protein catabolism as
een by the increase in mass of the extensor digitorium longus and
oleus muscles in treated animals. The activation of Akt is probably
ssociated with the presence of catechins in the aqueous extract of
he stem bark of Caesalpinia ferrea. Daisy et al. (2010) have shown
hat diabetic animals treated with catechins isolated from Cassia
stula exhibited increased expression of GLUT 4 mRNA and protein
GLUT4) in skeletal muscle even in the absence of regeneration of
ancreatic  cells destroyed by STZ.
The reduction in protein catabolism decreases hepatic uptake
f amino acids and, consequently, the serum levels of uric acid,
rea as well as ALT, AST and AlkP, as seen in treated animals. The
eduction in the levels of ALT, AST and AlkP may  also be explained
y the hepatoprotective effect of catechins. According to Tsuchiya
2001), catechins from Camellia sinensis improved the ﬂuidity of the
epatocyte membrane.
Another molecular pathway investigated was  the AMP-
ctivated protein kinase. Under conditions of energy depletion,
MPK activation inhibits ATP-consuming pathways and stimulates
he generation of ATP. AMPK activation leads to the de-activation
f ACC, which allows the oxidation of fatty acids, in an attempt to
estore energy balance (Zhou et al., 2001). The increase in AMPK
ctivity and subsequent de-activation of ACC explain the low lev-
ls of total cholesterol, triglycerides and epididymal adipose tissue
ass found in untreated diabetic animals.
Therefore, the reduced activation of AMPK in the skeletal mus-
le and increased activation of ACC in the skeletal muscle and in
he liver of treated animals suggest a restoration of the energy bal-
nce. However, in the liver of the treated animals, the increase of
lycogen was not sufﬁcient to suppress the activation of AMPK.
ccording to Winder and Hardie (1999),  the -subunits of AMPK
ave a glycogen binding domain and high concentrations of glyco-
en suppress AMPK activity.
The treatment with Caesalpinia ferrea decreased oxidative stress
n the liver and serum of diabetic animals. Ulicná et al. (2006)
howed that aqueous extract of the leaves of Aspalantus linearis
300 mg/kg) also prevents oxidative stress in diabetic rats. Moure
t al. (2001) have shown that tannins and catechins act as free
adical scavengers.
The catechins present in Caesalpinia ferrea could act to inhibit
oth digestive enzymes and the glucose transporter in the intestine.
n vivo studies conﬁrmed that catechins inhibited -glucosidase in
n oral glucose tolerance test (Li et al., 2007) and condensed tannins
rom black bean inhibited the sodium-dependent intestinal glucose
ptake system (Carmona et al., 1996).
As noted in this study, the improvement in glucose metabolism
n diabetic animals treated could be due to Akt activation, in the
iver and muscle, with consequent suppression in the activation of
MPK in the muscle. Thus, our study suggests a putative molecular
echanism for the action of the aqueous extract of the stem bark
f Caesalpinia ferrea and indicates that it is a promising alternative
reatment for diabetic conditions.harmacology 137 (2011) 1533– 1541
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